期刊文献+

南方红豆杉与引种德国曼地亚红豆杉茎、叶中紫杉醇和10-脱乙酰巴卡亭Ⅲ含量的比较 被引量:9

The contents comparison of taxol and 10-deacetyl bacatinⅢin stems and leaves between Taxus chinensis mairei and Taxus x media
暂未订购
导出
摘要 目的:建立HPLC法同时测定并比较南方红豆杉与德国引种曼地亚红豆杉茎、叶中紫杉醇和10-脱乙酰巴卡亭Ⅲ含量。方法采用CosmasilTMC18色谱柱(250mm×4.6mm,5μm);以乙腈-水(50∶50)为流动相;流速为1.0mL·min-1;检测波长为227nm;柱温:30℃。结果紫杉醇、10-脱乙酰巴卡亭Ⅲ的线性范围分别为2.675~42.8μg·mL-1(r=0.9993)和3.875~62μg·mL-1(r=0.9996),平均加样回收率(n=9)分别为98.1%和101.6%,RSD分别为2.7%和2.3%。南方红豆杉与德国引种曼地亚红豆杉的茎、叶中紫杉醇含量分别为0.12和0.10mg·g^-1,10-脱乙酰巴卡亭Ⅲ含量分别为0.12和0.14mg·g^-1。结论引种红豆杉与南方红豆杉在同一地区的生态环境下生长,茎、叶中所含紫杉醇和10-脱乙酰巴卡亭Ⅲ含量有显著性差异(P<0.05)。所建立方法准确,简便,适用于红豆杉的质量评价,为不同栽培品种的选择提供参考。 Objective To determine and compare the contents of taxol and 10-deacetyl bacatin Ⅲ in stems and leaves between Taxus chinensis mairei and Taxus x media by HPLC .Methods The isolation was performed on a CosmasilTM C18 column(250 mm × 4 .6 mm ,5 μm) with the mobile phase consisting of acetonitrile-water(50∶50) .The flow rate was 1 .0 mL · min-1 and the column temperature was set at 30 ℃ .Results The standard curves were linear within the ranges of 2 .675-42 .8 μg ·mL -1 for taxol(r=0 .999 3) ,and 3 .875-62 μg · mL -1 for 10-deacetyl bacatin Ⅲ (r=0 .999 6);The average recoveries were 98 .1% and 101 .6% , RSD were 2 .7% and 2 .3% .The contents of taxol in Taxus chinensis mairei and Taxus x media were 0 .12 and 0 .10 mg · g -1 , respectively ,while 10-deacetyl bacatin were 0 .12 and 0 .14 mg · g -1 ,respectively .Conclusion Although growing in the same eco-logical environment ,significant differences(P〈0 .05) of the contents of taxol and 10-deacetyl bacatin Ⅲ in stems and leaves were observed between Taxus chinensis mairei and Taxus x media .The method is simple and could be used as a quality control method for Taxus plants .
作者 宋秋烨
出处 《西北药学杂志》 CAS 2014年第2期129-132,共4页 Northwest Pharmaceutical Journal
关键词 紫杉醇 10-脱乙酰巴卡亭Ⅲ 南方红豆杉 曼地亚红豆杉 含量 taxol 10-deacetyl bacatin Taxus chinensis mairei Taxus x media contents
  • 相关文献

参考文献8

  • 1张学玉,曲玮,梁敬钰.红豆杉属植物化学成分及药理作用研究进展[J].海峡药学,2011,23(6):5-9. 被引量:36
  • 2陈建龙,任丽莉,陈国广.紫杉醇靶向制剂的研究进展[J].西北药学杂志,2011,26(5):390-390. 被引量:13
  • 3Gueritte Voegelein F, Guenard D, Lavelle F, et al. Re lationships between the structure of taxol analogs and their antimitotie aetivity[J]. J Med Chem, 1991, 34(3): 992-998.
  • 4阎家麒,尹嘉庆.我国红豆杉植物资源考察及紫杉醇研究开发的现状[J].中草药,1996,27(A09):198-202. 被引量:8
  • 5Christen A A, Gibson D M, Bland J. Production of tax- ol or taxol-like compounds in cell culture: USA, 5019504[P]. 1991 05-28.
  • 6Holton R A, Somoza C, Kim H B, et al. First total synthesis of taxol. 1. Functionalization of the B ring[J]. J Am Chem Soc, 1994, 116(4) : 1597-1598.
  • 7Nicolaou K C, Yang Z, Liu J J, et al. Total synthesis of taxol[J]. Nature, 1994, 367(6464): 630-634.
  • 8Chattopadhyay S K, Sharma R P, Kumar S. Process for the production of important taxol analogues 10-deacetyl taxol A, B, and C.. USA,6028206[P]. 2000-02-22.

二级参考文献74

  • 1Man Li ZHANG,Li Geng LI,Cong Mei CAO,Zuo Ping LI,Qing Wen SHI,Hiromasa KIYOTA.A New Abeotaxane Diterpenoid from the Seeds of Taxus mairei[J].Chinese Chemical Letters,2006,17(1):27-30. 被引量:1
  • 2林本兰,沈晓冬,崔升,施瑞华,凌亭生.磁性靶向紫杉醇微球制备的初步研究[J].中国新药杂志,2006,15(13):1081-1083. 被引量:6
  • 3杨涛,吴宗群,解建国.抗肿瘤紫杉醇的实验与临床应用进展[J].大连医科大学学报,2007,29(2):197-199. 被引量:9
  • 4Anil K Singla, Alka Garg, Deepika Aggarwal. Paclitaxel and its formulations[J]. Int J Pharm, 2002 , 235 :179 192.
  • 5Sudhir H Ranganath, Yilong Fu,Davis Y, et ah The use of submicron/nanoscale PLGA implants to deliver pacli- taxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice[J]. Biomaterial, 2010,31 : 5199-5207.
  • 6Sudhir H Ranganath,Chi-Hwa Wang. Biodegradable mierofiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma[J]. Biomaterial, 2008,29 : 2996-3003.
  • 7Benjamin Y S Ong,Ranganath SH,Lee LY,et al. Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme[J]. Biomaterial, 2009,30 : 3189-3196.
  • 8Yogesh Patil,Tanmoy Sadhukha, Linan Ma, et al. Nano- particle-mediated simultaneous and targeted delivery of paclitaxel and ariquidar overcomes tumor drug resistance [J]. J Control Release,2009,136:21-29.
  • 9Mika Pulkkinen,Jere Pikkarainen,Thomas Wirth, et al. Three-step tumor targeting of paclitaxel using biotiny lated PLA-PEG nanoparticles and avidin biotin technol ogy: Formulation development and in vitro anticancer ac tivity[J]. Eur J Pharm Biopharm, 2008,70 :66-74.
  • 10Yu De-Hong, Qin Lu, Xie Jing, et al. Peptide-conjugated biodegradable nanoparticles as a ca xel to tumor neovasculature[J]. Biomaterials, 2010,31 : 2278-2292.

共引文献54

同被引文献100

引证文献9

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部